Mary Mathieu
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Protein purification and stability, Recreation, Leisure, Wilderness Management, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → IgG Fc engineering to modulate antibody effector functions(2017)343 cited
- → Receptor-selective Mutants of Apoptosis-inducing Ligand 2/Tumor Necrosis Factor-related Apoptosis-inducing Ligand Reveal a Greater Contribution of Death Receptor (DR) 5 than DR4 to Apoptosis Signaling(2004)280 cited
- → Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies(2015)269 cited
- → Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells(2014)156 cited
- → An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia(2016)152 cited
- → Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin(2016)118 cited
- → Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies(2013)113 cited
- → Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody(2020)96 cited
- → Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite(2012)78 cited
- → Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab(2016)72 cited